Pharmacological Activation of Estrogen Receptor Beta Overcomes Tumor Resistance to Immune Checkpoint Blockade Therapy

The emerging immune checkpoint blockade (ICB) therapy has ushered the cancer therapeutics field into an era of immunotherapy. Although ICB treatment provides remarkable clinical responses in a subset of patients with cancer, this regimen fails to extend survival in a large proportion of patients. He...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:iScience
Main Authors: Huang, Shuang, Zhou, Nianxin, Zhao, Linjie, Gimple, Ryan C., Ahn, Young Ha, Zhang, Peidong, Wang, Wei, Shao, Bin, Yang, Jingyun, Zhang, Qian, Zhao, Sai, Jiang, Xuehan, Chen, Zhiwei, Zeng, Yangfan, Hu, Hongbo, Gustafsson, Jan-Åke, Zhou, Shengtao
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7476860/
https://ncbi.nlm.nih.gov/pubmed/32861994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.isci.2020.101458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados